Brief: IRLAB Q2 Sales SEK 19.5 Million
27/08/2025 06:00
Aug 27 (Reuters) - IRLAB Q2 operating cash flow SEK -42.6 million. Q2 EBIT SEK -25.7 million Q2 adjusted EPS SEK -0.62
IRLAB A — IRLAB Therapeutics AB News Story
0.000.00%
Last trade - 00:00- SEK165.12m
- SEK155.10m
- SEK57.46m